(Q45925272)

17 December 2017

title

Impact of the metabolic syndrome and its individual components on risk and severity of coronary heart disease. (English)

1 reference

17 December 2017

1 reference

Yifei Zhang

1

1 reference

17 December 2017

Jie Hong

2

1 reference

17 December 2017

Weiqiong Gu

3

1 reference

17 December 2017

Minghui Gui

4

1 reference

17 December 2017

Ying Chen

5

1 reference

17 December 2017

Yu Zhang

6

1 reference

17 December 2017

Zhenni Chi

7

1 reference

17 December 2017

Weiqing Wang

8

1 reference

17 December 2017

Xiaoying Li

9

1 reference

17 December 2017

Guang Ning

10

1 reference

17 December 2017

publication date

18 July 2009

1 reference

17 December 2017

published in

Endocrine

1 reference

17 December 2017

volume

36

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

233-238

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1007/s12020-009-9214-y

exact match

0 references

cites work

The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

12 December 2020

Metabolic syndrome: a solution in search of a problem

1 reference

12 December 2020

Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study

1 reference

12 December 2020

The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.

1 reference

12 December 2020

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study

1 reference

12 December 2020

Impact of Insulin Resistance on Risk of Type 2 Diabetes and Cardiovascular Disease in People With Metabolic Syndrome

1 reference

12 December 2020

Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease?

1 reference

12 December 2020

Impact of the metabolic syndrome on macrovascular and microvascular outcomes in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study 78.

1 reference

12 December 2020

Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population

1 reference

12 December 2020

Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies

1 reference

12 December 2020

Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS).

1 reference

12 December 2020

Does the new International Diabetes Federation definition of the metabolic syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study

1 reference

12 December 2020

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

1 reference

12 December 2020

Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies

1 reference

12 December 2020

Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study

1 reference

12 December 2020

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

12 December 2020

Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged chinese

1 reference

12 December 2020

The myth of the metabolic syndrome

1 reference

12 December 2020

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

1 reference

12 December 2020

10.1007/S12020-009-9214-Y

Identifiers

DOI

1 reference

17 December 2017

Dimensions Publication ID

1014587843

0 references

1 reference

17 December 2017